OMER FY 2012 Earnings — Omeros Corporation Revenue & Financial Results | Market Cap Arena

OMEROmeros Corporation

$826M

FY 2012 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$6M+33.1% YoY

Gross Profit

$6M99.7% margin

Operating Income

-$37M-612.5% margin

Net Income

-$38M-638.4% margin

EPS (Diluted)

$-1.59

Cash Flow

Operating Cash Flow

-$35M

Free Cash Flow

-$35M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$27M

Total Liabilities

$241M

Stockholders' Equity

-$215M

Cash & Equivalents

$2M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6M	$5M	+33.1%
Gross Profit	$6M	$5M	+32.7%
Operating Income	-$37M	-$27M	-34.6%
Net Income	-$38M	-$29M	-34.7%